Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32N2O5.C7H8O3S |
Molecular Weight | 540.669 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]23C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]2([H])CCCC3)C(O)=O
InChI
InChIKey=FWZROZSADJGJER-MHXJNQAMSA-N
InChI=1S/C19H32N2O5.C7H8O3S/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24;1-6-2-4-7(5-3-6)11(8,9)10/h12-16,20H,4-11H2,1-3H3,(H,23,24);2-5H,1H3,(H,8,9,10)/t12-,13-,14-,15-,16-;/m0./s1
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | PRESTALIA Approved UsePerindopril tosilate/Amlodipine is prescribed for treatment of high blood pressure (hypertension) Launch Date2015 |
|||
Primary | PRESTALIA Approved UsePerindopril tosilate/Amlodipine is prescribed for treatment of stable coronary artery disease. Launch Date2015 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000141420
Created by
admin on Sat Dec 16 09:03:50 GMT 2023 , Edited by admin on Sat Dec 16 09:03:50 GMT 2023
|
PRIMARY | |||
|
1258291-80-3
Created by
admin on Sat Dec 16 09:03:50 GMT 2023 , Edited by admin on Sat Dec 16 09:03:50 GMT 2023
|
PRIMARY | |||
|
49831214
Created by
admin on Sat Dec 16 09:03:50 GMT 2023 , Edited by admin on Sat Dec 16 09:03:50 GMT 2023
|
PRIMARY | |||
|
G092350E9M
Created by
admin on Sat Dec 16 09:03:50 GMT 2023 , Edited by admin on Sat Dec 16 09:03:50 GMT 2023
|
PRIMARY | |||
|
SUB91723
Created by
admin on Sat Dec 16 09:03:50 GMT 2023 , Edited by admin on Sat Dec 16 09:03:50 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD